Logo image of HPH

HIGHEST PERFORMANCES HOLDING (HPH) Stock Fundamental Analysis

NASDAQ:HPH - Nasdaq - US69373Y2081 - ADR - Currency: USD

6.65  +0.8 (+13.68%)

After market: 6.61 -0.04 (-0.6%)

Fundamental Rating

3

Overall HPH gets a fundamental rating of 3 out of 10. We evaluated HPH against 230 industry peers in the Capital Markets industry. No worries on liquidiy or solvency for HPH as it has an excellent financial health rating, but there are worries on the profitability. HPH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

HPH had negative earnings in the past year.
HPH had a positive operating cash flow in the past year.
In the past 5 years HPH always reported negative net income.
In the past 5 years HPH reported 4 times negative operating cash flow.
HPH Yearly Net Income VS EBIT VS OCF VS FCFHPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

HPH's Return On Assets of -7.57% is on the low side compared to the rest of the industry. HPH is outperformed by 84.35% of its industry peers.
The Return On Equity of HPH (-24.33%) is worse than 84.35% of its industry peers.
Industry RankSector Rank
ROA -7.57%
ROE -24.33%
ROIC N/A
ROA(3y)-12.12%
ROA(5y)-10.77%
ROE(3y)-21.75%
ROE(5y)-17.73%
ROIC(3y)N/A
ROIC(5y)N/A
HPH Yearly ROA, ROE, ROICHPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

1.3 Margins

Looking at the Gross Margin, with a value of 40.70%, HPH is doing worse than 63.91% of the companies in the same industry.
In the last couple of years the Gross Margin of HPH has declined.
HPH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.86%
GM growth 5Y-14.09%
HPH Yearly Profit, Operating, Gross MarginsHPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

More info and screens

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, HPH has about the same amount of shares outstanding.
Compared to 5 years ago, HPH has more shares outstanding
The debt/assets ratio for HPH is higher compared to a year ago.
HPH Yearly Shares OutstandingHPH Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
HPH Yearly Total Debt VS Total AssetsHPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

HPH has an Altman-Z score of 3.02. This indicates that HPH is financially healthy and has little risk of bankruptcy at the moment.
HPH's Altman-Z score of 3.02 is fine compared to the rest of the industry. HPH outperforms 76.96% of its industry peers.
HPH has a debt to FCF ratio of 1.84. This is a very positive value and a sign of high solvency as it would only need 1.84 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.84, HPH belongs to the best of the industry, outperforming 83.04% of the companies in the same industry.
HPH has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.07, HPH belongs to the top of the industry, outperforming 80.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.84
Altman-Z 3.02
ROIC/WACCN/A
WACCN/A
HPH Yearly LT Debt VS Equity VS FCFHPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 2.80 indicates that HPH has no problem at all paying its short term obligations.
HPH has a better Current ratio (2.80) than 80.87% of its industry peers.
HPH has a Quick Ratio of 2.80. This indicates that HPH is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.80, HPH belongs to the top of the industry, outperforming 80.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.8
Quick Ratio 2.8
HPH Yearly Current Assets VS Current LiabilitesHPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for HPH have decreased strongly by -1043.15% in the last year.
HPH shows a strong growth in Revenue. In the last year, the Revenue has grown by 967.12%.
The Revenue has been growing by 42.29% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-1043.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-831.4%
Revenue 1Y (TTM)967.12%
Revenue growth 3Y83.7%
Revenue growth 5Y42.29%
Sales Q2Q%2476.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HPH Yearly Revenue VS EstimatesHPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HPH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HPH Price Earnings VS Forward Price EarningsHPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HPH is valued a bit cheaper than 61.74% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as HPH.
Industry RankSector Rank
P/FCF 224.78
EV/EBITDA 305.48
HPH Per share dataHPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HPH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HIGHEST PERFORMANCES HOLDING

NASDAQ:HPH (5/2/2025, 8:00:01 PM)

After market: 6.61 -0.04 (-0.6%)

6.65

+0.8 (+13.68%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-04 2024-03-04/amc
Earnings (Next)N/A N/A
Inst Owners0.03%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.65B
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.84
P/FCF 224.78
P/OCF 208.02
P/B 9.02
P/tB 17.92
EV/EBITDA 305.48
EPS(TTM)-0.21
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.03
FCFY0.44%
OCF(TTM)0.03
OCFY0.48%
SpS0.68
BVpS0.74
TBVpS0.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.57%
ROE -24.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.7%
FCFM 4.38%
ROA(3y)-12.12%
ROA(5y)-10.77%
ROE(3y)-21.75%
ROE(5y)-17.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.86%
GM growth 5Y-14.09%
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.84
Debt/EBITDA 2.85
Cap/Depr 4.47%
Cap/Sales 0.35%
Interest Coverage N/A
Cash Conversion 167.23%
Profit Quality N/A
Current Ratio 2.8
Quick Ratio 2.8
Altman-Z 3.02
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)35.28%
Cap/Depr(5y)99.73%
Cap/Sales(3y)1.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1043.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-831.4%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)967.12%
Revenue growth 3Y83.7%
Revenue growth 5Y42.29%
Sales Q2Q%2476.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y296.13%
FCF growth 3YN/A
FCF growth 5Y-10.53%
OCF growth 1Y327.63%
OCF growth 3YN/A
OCF growth 5Y-10.05%